This second commercial clip in our series explores the next chapter of our partnership with Carolina Martinez — a story not just of resilience, but of collaboration.

Why would a bioanalytical CRO team up with a college runner? Because Carolina Martinez’s journey mirrors the very reason Veloxity Labs exists: to help save lives.

Carolina Martinez’s journey from patient to record-setter reflects the power of science, purpose and perseverance—and it’s a reminder of the human impact behind everything we do.

Non-liquid matrices are the future of bioanalysis, and Veloxity Labs is leading the charge. Read the report.

The 2025 FDA Biomarker Guidance is finally here, but it’s not without its gaps. Read our report for a breakdown of what’s new, what’s missing, and what it means for your biomarker strategy.

Check out this QAU audits report to learn more about how our systems and processes allow us to proactively address any challenges, collaborate with principal investigators (PIs) and continuously refine our workflow to drive better outcomes for you!

Read this report for a detailed comparison between conventional pharmacokinetic/toxicokinetic (PK/TK) workflows and a modern, fully integrated approach.

Download this report to learn how we leverage velocity to achieve optimal outcomes, maintain the highest standards and more.